ABH Healthcare IPO GMP today is Rs 0. Investors can use this GMP along with price band and subscription status for a better IPO review.
Closed
SME IPO
ABH
ABH Healthcare IPO GMP, Subscription & Allotment Status Today
ABH Healthcare operates a 150-bed multi-specialty tertiary care hospital in Ferozepur, Punjab, under the brand “Anil Baghi Hospital.” The company focuses on providing a wide range of healthcare services, including advanced clinical care across approximately 25 specialties. Core disciplines include cardiac sciences, neurology, minimally invasive spine and brain surgeries, gastroenterology, orthopedics, and joint replacement. The hospital generates revenue through a mix of in-patient and out-patient services, supported by a network of over 30 public and private insurance companies and TPAs. Operations are supported by a robust infrastructure that includes an in-house pharmacy, a pathology laboratory, and advanced medical equipment. The business model is centered on delivering comprehensive and accessible medical care, from emergency services and critical care to specialized treatments, to the community in and around the Tier-3 city of Ferozepur.
- Price Band
- ₹96.00 - ₹102.00
- Lot Size
- 1,200 Shares
- Bidding Closes
- 26 Aug 2026
- Listing Date
- 31 Aug 2026
Current GMP Status
₹0
+0% vs upper band
Est. Listing Gain
+0.00%
Last Trend
27 Aug 2026
Listing Price
Est. ₹102
Retail Entry
₹2,44,800
IPO Details
Complete IPO information
| Current GMP | ₹0 |
|---|---|
| Estimated Listing Gain | +0.00% |
| Price Band | ₹96.00 - ₹102.00 |
| Issue Price | Approx ₹34.98 Crores |
| Listing Price | Est. ₹102 |
| Lot Size | 1,200 Shares |
| Issue Type | SME |
| Registrar | TBA |
| Exchange | NSE SME |
| Retail Quota | TBA |
| Overall Subscription | 1.44x |
| Listing Date | 31 Aug 2026 |
| Minimum Investment | ₹2,44,800 |
Demand Tracker
Subscription Status
| Category | Shares Reserved | Shares Applied | Subscription (x) |
|---|---|---|---|
| QIB | 1.99 | 16.67 | 8.37x |
| NII | 1.71 | 4.37 | 0.29x |
| Retail | 15.29 | 25.78 | 1.69x |
| Overall Subscription | 34.30 | 46.81 | 1.44x |
Head-to-head
Compare ABH Healthcare IPO with similar IPOs
Analysis
IPO Snapshot & Investor Takeaways
At the upper end of its price band, ABH Healthcare is priced at ₹102 per share. With a minimum lot size of 1,200 shares, a retail investor applying for one lot would need approximately ₹2,44,800 to participate in this SME issue.
The latest recorded Grey Market Premium for ABH Healthcare stands at ₹0, implying an estimated listing gain of around 0.00% over the issue price if it holds until listing. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.
As of the latest update, ABH Healthcare's IPO was subscribed 1.44x overall, with a category-wise breakdown of Retail 1.69x, QIB 8.37x, NII 0.29x.
Among the strengths highlighted in ABH Healthcare's IPO documents: Doctor-led professional management team with proven execution capabilities.; Track record of delivering quality clinical care by attracting and retaining renowned clinicians..
Investors should also weigh the risk factors ABH Healthcare has disclosed, including: Significant dependency on key personnel, including promoters and healthcare professionals..
A share of ABH Healthcare's issue proceeds is earmarked for Repayment Of Borrowings: 17 (48.60%).
SME IPOs list on the dedicated SME platform of BSE/NSE. They usually involve smaller issue sizes and a higher per-lot investment than Mainboard issues, with comparatively lower institutional participation.
Timeline
IPO roadmap at a glance
✓
Bidding Opens
24 Aug 2026
✓
Bidding Closes
26 Aug 2026
03
Allotment Next
27 Aug 2026
04
Listing
31 Aug 2026
Grey Market Premium
Daily GMP status
| Date | GMP | Change | Gain |
|---|---|---|---|
| 27 Aug 2026 | ₹0.00 | - | TBA |
| 26 Aug 2026 | ₹0.00 | - | TBA |
| 25 Aug 2026 | ₹0.00 | - | TBA |
| 24 Aug 2026 | ₹0.00 | - | TBA |
| 19 Aug 2026 | ₹0.00 | - | 0.00% |
Swipe to see more →
Market Lot
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 Lot | 2,400 | ₹2,44,800 |
| Retail Maximum | 2 Lot | 2,400 | ₹2,44,800 |
| S-HNI Minimum | 3 Lot | 3,600 | ₹3,67,200 |
| S-HNI Maximum | 8 Lot | 9,600 | ₹9,79,200 |
| B-HNI Minimum | 9 Lot | 10,800 | ₹11,01,600 |
Swipe to see more →
Fund Utilization
Objects of the Issue & Official Documents
- Repayment Of Borrowings 17 (48.60%)
- Working Capital 5 (14.29%)
- General Corporate Purpose 12.98 (37.11%)
Issue Notes
Important takeaways before applying
Strengths
- Doctor-led professional management team with proven execution capabilities.
- Track record of delivering quality clinical care by attracting and retaining renowned clinicians.
- Diversified operations across multiple clinical specialties, payor mix, and hospitals.
- Robust operating infrastructure, including modern information technology and medical equipment.
- Consistent track record of stable operating and financial performance and growth.
Risks
- Significant dependency on key personnel, including promoters and healthcare professionals.
- Revenues are significantly dependent on a single hospital located in Ferozepur, Punjab.
- Inability to keep pace with technological changes and new equipment may adversely affect business.
- Business is subject to legal claims and regulatory actions arising from healthcare services.
- The company does not own the premises for its hospital, which operates on a leasehold basis.
Analysis
ABH Healthcare IPO Details
The ABH Healthcare IPO is an NSE SME book-building issue with a total issue size of approximately ₹34.98 crores. The public offer consists entirely of a fresh issue, meaning the proceeds from the issue will be received by the company, subject to issue-related expenses.
The IPO is scheduled to open for subscription on August 24, 2026 and close on August 26, 2026. ABH Healthcare has fixed the IPO price band at ₹96 to ₹102 per equity share, while the face value is ₹10 per share. The company's equity shares are proposed to be listed on the NSE SME platform.
| Particular | Details |
|---|---|
| IPO Open Date | August 24, 2026 |
| IPO Close Date | August 26, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹96 to ₹102 Per Share |
| Issue Size | Approx ₹34.98 Crores |
| Fresh Issue | Approx ₹34.98 Crores |
| Issue Type | Book Building Issue |
| IPO Listing | NSE SME |
Note: ABH Healthcare operates in the healthcare sector and acquired the Anil Baghi Hospital business. Its earlier offer document proposed an issue of up to 34,29,000 fresh equity shares. Investors should evaluate the company's financial performance, use of proceeds, valuation, healthcare industry outlook and IPO risk factors before investing.
Analysis
ABH Healthcare IPO Reservation
The ABH Healthcare IPO reservation is divided among Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), Retail Individual Investors and other applicable categories.
As per the provided allocation, 1,99,200 shares are offered to Qualified Institutional Buyers excluding anchor investors. The NII category is allocated 15,28,800 shares, representing approximately 44.58%, while Retail Individual Investors are also offered 15,28,800 shares, representing approximately 44.58% of the issue.
| Investor Category | Shares Offered | Shares (%) |
|---|---|---|
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | 1,99,200 Shares | -% |
| NII Shares Offered | 15,28,800 Shares | 44.58% |
| Retail Shares Offered | 15,28,800 Shares | 44.58% |
Note: The exact percentage allocation for the QIB (Ex. Anchor) category is not available in the provided data. The table therefore retains the supplied share allocation without estimating the missing percentage.
Analysis
ABH Healthcare IPO Dates
The ABH Healthcare IPO will open for subscription on August 24, 2026 and close on August 26, 2026. Investors can submit their IPO applications during this three-day subscription period.
The ABH Healthcare IPO allotment is expected to be finalized on August 27, 2026. Refunds for unsuccessful applicants and credit of shares to successful investors' demat accounts are scheduled for August 28, 2026. The shares are scheduled to list on the NSE SME platform on August 31, 2026.
| IPO Event | Date |
|---|---|
| IPO Open Date | August 24, 2026 |
| IPO Close Date | August 26, 2026 |
| Basis of Allotment | August 27, 2026 |
| Refunds | August 28, 2026 |
| Credit to Demat Account | August 28, 2026 |
| IPO Listing Date | August 31, 2026 |
Note: The above table summarizes the ABH Healthcare IPO timeline, including the opening date, closing date, basis of allotment, refund initiation, demat credit and proposed NSE SME listing date.
Analysis
ABH Healthcare IPO Promoters and Holding Pattern
The promoters of ABH Healthcare are Kamal Baghi, Saurabh Baghi and Vaishali Saini. Before the IPO, the promoter and promoter group collectively hold substantially the entire equity share capital of the company.
The promoter and promoter group hold 79,99,996 equity shares, representing approximately 100% of the pre-IPO share capital. Other shareholders hold only 4 equity shares, representing a negligible percentage of the company's pre-issue capital.
Following completion of the fresh issue, the company's total outstanding equity shares are expected to increase from 80,00,000 shares before the IPO to approximately 1,14,29,600 shares after the IPO.
Promoters of ABH Healthcare
- Kamal Baghi
- Saurabh Baghi
- Vaishali Saini
| Particular | Pre IPO Shares | Pre IPO % Shares | Post IPO Shares | Post IPO % Shares |
|---|---|---|---|---|
| Promoter and Promoter Group | 79,99,996 | 100% | – | -% |
| Others* | 4 | 0% | – | -% |
| Total | 80,00,000 | 100% | 1,14,29,600 | 100% |
Note: Post-IPO promoter and public shareholding percentages are not available in the provided data. The total post-issue share capital is expected to increase to 1,14,29,600 equity shares following completion of the fresh issue.
Analysis
ABH Healthcare IPO Objects of the Issue & Utilisation of Proceeds
ABH Healthcare proposes to utilise the proceeds from the fresh issue primarily towards repayment or prepayment of existing borrowings and funding the company's working capital requirements. The remaining proceeds are proposed to support inorganic growth opportunities and general corporate purposes.
The company intends to utilise approximately ₹17.00 crores towards repayment or prepayment, in part or full, of certain borrowings. Another ₹4.30 crores is proposed to be utilised towards working capital requirements to support the company's ongoing healthcare operations.
| Purpose | Amount |
|---|---|
| Repayment / prepayment, in part or full, of certain borrowings | ₹17.00 Cr. |
| Funding the Company's Working Capital Requirements | ₹4.30 Cr. |
| Funding inorganic growth through unidentified acquisitions and general corporate purposes | ₹- |
Note: The specified utilisation towards repayment of borrowings and working capital requirements totals approximately ₹21.30 crores. The remaining net proceeds may be utilised towards inorganic growth through unidentified acquisitions and general corporate purposes in accordance with the offer document.
Analysis
ABH Healthcare About IPO
ABH Healthcare, which operates under the brand “Anil Baghi Hospital,” is a healthcare service provider. It is a multi-speciality hospital brand that provides 25 medical specialties: cardiac sciences, neurology, minimally invasive spine and brain surgeries, medical and surgical gastroenterology, laparoscopic and bariatric surgery, urology, pulmonology, nephrology, ENT, maxillofacial surgeries, etc.
ABH Healthcare offers healthcare services under various government healthcare schemes and organisations, including ECHS, Indian Railways, FCI, BSNL, and Ayushman Bharat–Sarbat Sehat Bima Yojana (ABSSBY). As of FY25, the firm includes 29 doctors and 137 nurses. Its competitive strengths are a professional management team, providing quality clinical care, modern equipment, and a track record of stable financial growth.
Analysis
ABH Healthcare IPO Company Financial Report
ABH Healthcare reported steady revenue growth between FY2024 and FY2026. Revenue increased from ₹41.39 crores in FY2024 to ₹49.32 crores in FY2025 and further reached ₹52.59 crores in FY2026.
The company's profitability improved more significantly over the same period. Profit After Tax (PAT) increased from ₹1.66 crores in FY2024 to ₹5.35 crores in FY2025 and ₹5.64 crores in FY2026. Total assets also expanded from ₹51.35 crores in FY2024 to ₹85.27 crores in FY2026.
| Period Ended | Revenue | Expense | PAT | Assets |
|---|---|---|---|---|
| 2024 | ₹41.39 Cr. | ₹39.19 Cr. | ₹1.66 Cr. | ₹51.35 Cr. |
| 2025 | ₹49.32 Cr. | ₹41.89 Cr. | ₹5.35 Cr. | ₹63.90 Cr. |
| 2026 | ₹52.59 Cr. | ₹44.66 Cr. | ₹5.64 Cr. | ₹85.27 Cr. |
Amount in ₹ Crores: The above table summarizes ABH Healthcare's revenue, expenses, Profit After Tax (PAT) and total assets from FY2024 to FY2026. The reported figures show continued revenue growth along with a notable improvement in profitability and expansion of the company's asset base.
Analysis
ABH Healthcare IPO Valuation – FY2026
The ABH Healthcare IPO valuation can be evaluated using key financial indicators such as Earnings Per Share (EPS), Return on Equity (ROE), Return on Capital Employed (ROCE), EBITDA Margin, PAT Margin, debt-to-equity ratio, Return on Net Worth (RoNW) and Net Asset Value (NAV).
For FY2026, ABH Healthcare reported an ROE of 39.07% and ROCE of 19.09%. The company's EBITDA margin stood at 28.03%, while its PAT margin was 10.74%. The debt-to-equity ratio stood at 3.20, indicating relatively high financial leverage.
The company's basic Earnings Per Share (EPS) stood at ₹7.05, while Return on Net Worth (RoNW) was 39.07%. The Net Asset Value (NAV) was reported at ₹21.58 per equity share.
| KPI | Values |
|---|---|
| ROE | 39.07% |
| ROCE | 19.09% |
| EBITDA Margin | 28.03% |
| PAT Margin | 10.74% |
| Debt to Equity Ratio | 3.20 |
| Earning Per Share (EPS) | ₹7.05 (Basic) |
| Price / Earnings (P/E) Ratio | N/A |
| Return on Net Worth (RoNW) | 39.07% |
| Net Asset Value (NAV) | ₹21.58 |
Note: Based on the IPO price band of ₹96 to ₹102 and FY2026 EPS of ₹7.05, the implied P/E works out to approximately 13.62x to 14.47x. Investors should evaluate this valuation alongside the company's profitability, return ratios, debt levels, growth prospects and relevant industry peers.
Analysis
ABH Healthcare IPO Peer Group Comparison
The ABH Healthcare IPO peer group comparison helps investors compare the company's financial and valuation profile with listed healthcare and hospital companies. Key parameters include Earnings Per Share (EPS), Price-to-Earnings (P/E) ratio, Return on Net Worth (RoNW), Net Asset Value (NAV) and income.
The company's peer group includes Sangani Hospitals Limited, Maitreya Medicare Limited and Asarfi Hospital Limited. Since these companies differ in their operating scale, profitability and financial position, investors should consider the overall financial profile when comparing valuations.
| Company | EPS | P/E Ratio | RoNW % | NAV | Income |
|---|---|---|---|---|---|
| Sangani Hospitals Limited | 2.17 | 24.52 | 16.20% | 23.30 | 106.96 Cr. |
| Maitreya Medicare Limited | (3.64) | (34.11) | (8.10)% | 42.67 | 44.85 Cr. |
| Asarfi Hospital Limited | 8.47 | 27.63 | 18.65% | 49.62 | 173.50 Cr. |
Note: Based on ABH Healthcare's FY2026 EPS of ₹7.05 and IPO price band of ₹96–₹102, its implied P/E is approximately 13.62x–14.47x. This is lower than the positive P/E multiples shown for Sangani Hospitals and Asarfi Hospital; however, investors should also compare business scale, profitability, leverage, return ratios and growth prospects.
Analysis
IPO Lead Managers aka Merchant Bankers
- Fedex Securities Pvt.Ltd.
FAQ
ABH Healthcare IPO FAQs
ABH Healthcare IPO price band is Rs 96.00 to Rs 102.00. Check the latest issue price, lot size and GMP together before applying.
ABH Healthcare IPO open date is 24 Aug 2026, close date is 26 Aug 2026, and listing date is 31 Aug 2026.
ABH Healthcare IPO lot size is 1,200 shares. The minimum retail investment is Rs 2,44,800.
ABH Healthcare is classified as a SME IPO. This helps investors quickly understand the issue category and exchange segment.
ABH Healthcare IPO subscription status currently shows Retail 1.69x, QIB 8.37x, NII 0.29x, Overall 1.44x.
ABH Healthcare operates a 150-bed multi-specialty tertiary care hospital in Ferozepur, Punjab, under the brand “Anil Baghi Hospital.” The company focuses on providing a wide range of healthcare services, including advanced clinical care across approximately 25 specialties. Core disciplines include cardiac sciences, neurology, minimally invasive spine and brain surgeries, gastroenterology, orthopedics, and joint replacement. The hospital generates revenue through a mix of in-patient and out-patient services, supported by a network of over 30 public and private insurance companies and TPAs. Operations are supported by a robust infrastructure that includes an in-house pharmacy, a pathology laboratory, and advanced medical equipment. The business model is centered on delivering comprehensive and accessible medical care, from emergency services and critical care to specialized treatments, to the community in and around the Tier-3 city of Ferozepur.
ABH Healthcare IPO issue size is 34.98 and the expected allotment date is 27 Aug 2026.
Community discussion
Comments
Share a useful question or insight about ABH Healthcare.
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Keep Exploring
Similar Recent IPOs
SME
R.K.Fashion Accessories
Price Band₹77.00 - ₹82.00
Current GMP₹0
Lot Size1,600 Shares
SME
Dove Soft
Price Band₹104.00 - ₹111.00
Current GMP₹0
Lot Size1,200 Shares
SME
Paramount Syntex
Price Band₹119.00 - ₹127.00
Current GMP₹0
Lot Size1,000 Shares
SME
Omara Ventures India
Price Band₹296.00 - ₹311.00
Current GMP₹0
Lot Size400 Shares
Loading comments...